Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

  • Eli Lilly (LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of its only real competitor in the field, Novo Nordisk.